Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Abstract Background The plasma concentration of patients treated with efavirenz (EFV) 600 mg was found to exceed the upper limit of the proposed therapeutic window in most Chinese HIV-infected individuals; thus, dosage reduction of EFV to 400 mg daily warranted consideration. This study aimed to ass...
Main Authors: | Ling Xu, Wenxiu Peng, Xiaojing Song, Yanling Li, Yang Han, Ting Zhu, Qiang Fu, Xiaoli Du, Wei Cao, Taisheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-05802-8 |
Similar Items
-
The Distinction in Level of Stress, Anxiety, and Depression between Efavirenz with Nevirapine Therapies (Study on HIV/AIDS-infected patients at VCT-CST clinic Dr.Kariadi Hospital Semarang)
by: Muflihatunnaimah Muflihatunnaimah, et al.
Published: (2018-06-01) -
Selecting patients who can be re-challenged with Nevirapine in case of skin rash with Efavirenz – A Study
by: N. Dutta, et al.
Published: (2017-05-01) -
Relationship between epicardial fat volume measured by multi-detector computed tomography and coronary artery disease
by: Doaa Ashour Taha, et al.
Published: (2021-09-01) -
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
by: Ling Xu, et al.
Published: (2021-02-01) -
Unloading Bays as Charging Stations for EFV-Based Urban Freight Delivery System—Example of Szczecin
by: Stanisław Iwan, et al.
Published: (2021-09-01)